Oral folic acid versus placebo in the treatment of males with the fragile X syndrome

Randi J Hagerman, A. W. Jackson, A. Levitas, M. Braden, P. McBogg, M. Kemper, L. McGavran, R. Berry, I. Matus

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

A double-blind, crossover study of a 10 mg folic acid per day (vs. placebo) treatment was carried out in 25 fra(X) males (ages 1-31 years). Each treatment period lasted 6 months. Before, during and after the study, the patients were assessed blindly with psychological, language and behavioral evaluations, and parent or caretaker reports were collected. Standardized testing did not show statistically significant changes in the group as a whole; psychological testing demonstrated a statistically significant improvement on folic acid in the prepubertal males. After uncoding, caretaker or parent reports also demonstrated behavioral improvements in the prepubertal males while being treated with folic acid.

Original languageEnglish (US)
Pages (from-to)241-262
Number of pages22
JournalAmerican Journal of Medical Genetics
Volume23
Issue number1-2
StatePublished - 1986
Externally publishedYes

Fingerprint

Fragile X Syndrome
Folic Acid
Placebos
Psychology
Double-Blind Method
Cross-Over Studies
Language
Therapeutics

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

Hagerman, R. J., Jackson, A. W., Levitas, A., Braden, M., McBogg, P., Kemper, M., ... Matus, I. (1986). Oral folic acid versus placebo in the treatment of males with the fragile X syndrome. American Journal of Medical Genetics, 23(1-2), 241-262.

Oral folic acid versus placebo in the treatment of males with the fragile X syndrome. / Hagerman, Randi J; Jackson, A. W.; Levitas, A.; Braden, M.; McBogg, P.; Kemper, M.; McGavran, L.; Berry, R.; Matus, I.

In: American Journal of Medical Genetics, Vol. 23, No. 1-2, 1986, p. 241-262.

Research output: Contribution to journalArticle

Hagerman, RJ, Jackson, AW, Levitas, A, Braden, M, McBogg, P, Kemper, M, McGavran, L, Berry, R & Matus, I 1986, 'Oral folic acid versus placebo in the treatment of males with the fragile X syndrome', American Journal of Medical Genetics, vol. 23, no. 1-2, pp. 241-262.
Hagerman, Randi J ; Jackson, A. W. ; Levitas, A. ; Braden, M. ; McBogg, P. ; Kemper, M. ; McGavran, L. ; Berry, R. ; Matus, I. / Oral folic acid versus placebo in the treatment of males with the fragile X syndrome. In: American Journal of Medical Genetics. 1986 ; Vol. 23, No. 1-2. pp. 241-262.
@article{422fdc3a515040bea7181e9d72ca0c9f,
title = "Oral folic acid versus placebo in the treatment of males with the fragile X syndrome",
abstract = "A double-blind, crossover study of a 10 mg folic acid per day (vs. placebo) treatment was carried out in 25 fra(X) males (ages 1-31 years). Each treatment period lasted 6 months. Before, during and after the study, the patients were assessed blindly with psychological, language and behavioral evaluations, and parent or caretaker reports were collected. Standardized testing did not show statistically significant changes in the group as a whole; psychological testing demonstrated a statistically significant improvement on folic acid in the prepubertal males. After uncoding, caretaker or parent reports also demonstrated behavioral improvements in the prepubertal males while being treated with folic acid.",
author = "Hagerman, {Randi J} and Jackson, {A. W.} and A. Levitas and M. Braden and P. McBogg and M. Kemper and L. McGavran and R. Berry and I. Matus",
year = "1986",
language = "English (US)",
volume = "23",
pages = "241--262",
journal = "American Journal of Medical Genetics",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "1-2",

}

TY - JOUR

T1 - Oral folic acid versus placebo in the treatment of males with the fragile X syndrome

AU - Hagerman, Randi J

AU - Jackson, A. W.

AU - Levitas, A.

AU - Braden, M.

AU - McBogg, P.

AU - Kemper, M.

AU - McGavran, L.

AU - Berry, R.

AU - Matus, I.

PY - 1986

Y1 - 1986

N2 - A double-blind, crossover study of a 10 mg folic acid per day (vs. placebo) treatment was carried out in 25 fra(X) males (ages 1-31 years). Each treatment period lasted 6 months. Before, during and after the study, the patients were assessed blindly with psychological, language and behavioral evaluations, and parent or caretaker reports were collected. Standardized testing did not show statistically significant changes in the group as a whole; psychological testing demonstrated a statistically significant improvement on folic acid in the prepubertal males. After uncoding, caretaker or parent reports also demonstrated behavioral improvements in the prepubertal males while being treated with folic acid.

AB - A double-blind, crossover study of a 10 mg folic acid per day (vs. placebo) treatment was carried out in 25 fra(X) males (ages 1-31 years). Each treatment period lasted 6 months. Before, during and after the study, the patients were assessed blindly with psychological, language and behavioral evaluations, and parent or caretaker reports were collected. Standardized testing did not show statistically significant changes in the group as a whole; psychological testing demonstrated a statistically significant improvement on folic acid in the prepubertal males. After uncoding, caretaker or parent reports also demonstrated behavioral improvements in the prepubertal males while being treated with folic acid.

UR - http://www.scopus.com/inward/record.url?scp=0022575453&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022575453&partnerID=8YFLogxK

M3 - Article

C2 - 3513567

AN - SCOPUS:0022575453

VL - 23

SP - 241

EP - 262

JO - American Journal of Medical Genetics

JF - American Journal of Medical Genetics

SN - 1552-4825

IS - 1-2

ER -